Phreesia (PHR) Rule 144 Notice for 10,000 Common Shares on NYSE

Rhea-AI Filing Summary

Form 144 notice for Phreesia, Inc. (PHR) related activity. The filing reports a proposed Rule 144 sale of 10,000 common shares through Fidelity Brokerage Services with an aggregate market value of $300,000, to be sold approximately on 08/25/2025 on the NYSE. The shares correspond to two option grants originally awarded on 03/01/2018 (6,887 shares) and 03/27/2019 (3,113 shares), with cash payment noted. The filer previously sold a combined 10,000 shares on 06/09/2025 and 06/10/2025 for gross proceeds of $275,011.73. The signer certifies no undisclosed material adverse information.

Positive

• Transaction details disclosed: quantity, broker, exchange, approximate sale date, and aggregate market value are provided
• Acquisition basis disclosed: ties shares to specific option grants with grant dates
• Prior sales disclosed: two recent open-market sales in June 2025 with gross proceeds listed, improving transparency
• Seller certification: signer represents no undisclosed material adverse information

Negative

• Missing issuer identification in header: issuer name and related header fields are blank in the provided content, limiting easy verification
• Filer CIK/CCC not provided: filer identification fields are empty in the text supplied, hindering direct match to registrant records

Insights

Securities Analyst

TL;DR: Routine insider sale under Rule 144 totaling 10,000 shares; appears procedural with limited market impact.

The filing documents a proposed sale of 10,000 common shares via Fidelity with an aggregate value of $300,000, derived from previously granted options. The seller also disclosed two prior open-market sales in June 2025 matching 10,000 shares and ~ $275k in proceeds, indicating ongoing liquidity actions rather than a single large disposition. No issuer-specific financial data or new material events are disclosed in this notice, so market-impact is likely minimal absent other disclosures.

Corporate Governance Expert

TL;DR: Compliance-focused filing showing Rule 144 reliance; disclosure is standard but lacks some issuer identification fields.

The form follows Rule 144 mechanics by identifying the broker, class, quantity, and acquisition basis (option grants). The signer asserts there is no nonpublic material information. However, key issuer identifying fields in the header are blank in the provided text, which complicates cross-checking; the broker, dates, share counts, and prior sales are provided, supporting auditability of the trading history disclosed here.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	10000	300000.00	59504269	08/25/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/25/2025	Option Granted - 03/01/2018	Issuer			6887	08/25/2025	Cash
Common	08/25/2025	Option Granted - 03/27/2019	Issuer			3113	08/25/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael Weintraub 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	06/09/2025	7431	204443.92
Michael Weintraub 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	06/10/2025	2569	71567.81

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for PHR report?

The form reports a proposed sale of 10,000 common shares on the NYSE with an aggregate market value of $300,000, approx. sale date 08/25/2025.

Who is the broker and where will the PHR shares be sold?

The securities are to be sold through Fidelity Brokerage Services LLC and the transaction is expected to occur on the NYSE.

What is the acquisition source of the shares being sold under Rule 144 for PHR?

The 10,000 shares derive from option grants: 6,887 shares granted 03/01/2018 and 3,113 shares granted 03/27/2019, with payment noted as cash.

Did the filer recently sell any PHR shares?

Yes. The filer sold 7,431 shares on 06/09/2025 for $204,443.92 and 2,569 shares on 06/10/2025 for $71,567.81, totaling 10,000 shares and $275,011.73 gross proceeds.

Does the filing state there is any undisclosed material information?

The filer signs a representation that they do not know any material adverse information about the issuer that has not been publicly disclosed.